Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan,

Slides:



Advertisements
Similar presentations
EUROACTION: Changes in diet and physical activity over one year in a family based preventive cardiology programme in hospital and general practice Jennifer.
Advertisements

10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Main Trial Design and Trial Status
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning (NHMRC GP clinical research grant July ) PEACH:
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,
E NHANCING C OMPREHENSIVE HIV C ARE : Addressing Cardiovascular Disease (CVD) and other Noncommunicable Diseases (NCDs) Kwasi Torpey MD PhD MPH FGCP Deputy.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
The Role of the Nurse in Implementing CVD Prevention Guidelines Noeleen Fallon Clinical Nurse Specialist in Cardiac Rehabilitation AMNCH, Tallaght, Dublin.
OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Lipid Lowering Substudy Trial of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288: ALLHAT- LLT.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
The Effect of Chocolate Consumption on Cardiovascular Disease Risk Factors Stephanie Becker November 24, 2014.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Monthly Journal article review: Vimmi Kang PGY 2
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists. Ron JG Peters, MD On behalf of the RESPONSE Investigators Academic Medical.
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
中国农村心血管病防治面临的挑战 Challenges in prevention and control of CVD in Rural China Yangfeng Wu, MD, PhD The George Institute for Global Health at Peking University.
LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.
U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute ALLHAT Major Outcomes in Moderately.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
3 rd Annual Right Care Summit October 1 st, 2010 Stephen M. Shortell Ph.D., M.P.H. Dean, University of California, Berkeley, School of Public Health.
Tobacco, EXercise and dieT MEssages
BRIAN CLAYTON INTERNAL MEDICINE ADVISOR: ANNA MAE SMITH PRECEPTOR: DR. RAJESH PATEL Evidence Based Medicine Spring 2009.
Improving prevention Improve prevention: connect patients to lifestyle community networks, clinical pathways and new technology. Victor AWM Umans MD PhD.
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
 Ischaemic heart disease reduces blood supply to the heart muscles and is one of the major cardiovascular diseases.
Lipid Lowering Drug Prescribing: ‘patchy’ guideline adherence despite multi-faceted interventions M.E. Cupples 1, Terry Bradley, Chris Hall 1 Dept General.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Fixed-Dose Combination Strategy on Adherence.
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease (HOPE-3 trial) R4. 박은지 / PF. 정혜문 Salim Yusuf, M.B., B.S., D.Phil.,
Presentation Title R3 이지영 / 김 수 중교 수 님. Introduction Lowering LDL cholesterol levels with statins : Reduce the risk of cardiovascular disease Vascular.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Erectile Dysfunction and Cardiovascular Risk Dr Laura Backhouse Foundation Year 2 Gloucestershire Trust Prevent the 3 year progression from erectile dysfunction.
Journal Club Julie Shah, MD Milton S Hershey Medical Center Penn State University.
Fast fOod Shops Significantly Impact Cardiovascular Karma - the FOSSICK IV Trial - Reddy M, Luque M, Ferrer Ferrer L, Koju R, Zaman MJ, Inspiron D, Caprnda.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
SECONDARY PREVENTION IN HEART DISEASE CATHY QUICK AUBURN UNIVERSITY/AUBURN MONTGOMERY EBP III.
Findings suggest: Improvement was noted in both BMI and reported physical activity although the differences did not reach statistical difference. Behavior.
Statins The AURORA Trial Reference Fellstrom BC. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360. A.
The OPTImal CArdiac REhabilitation (OPTICARE) trial:
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Structured Physical Activity on Prevention.
From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):
The SPRINT Research Group
“MOVEdiabetes” 12 months intervention
Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations – A Systematic Review and Meta-analysis  Julie Sze, MBBS, John.
The Anglo Scandinavian Cardiac Outcomes Trial
Management of Type II Diabetes
Systolic Blood Pressure Intervention Trial (SPRINT)
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
LRC-CPPT and MRFIT Content Points:
The Heart Truth Delaware Background
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan, PhD; Nicholas Graves, PhD; Laura de Keizer, BSc (Nutr); Tony Barry, BSc; Severine Bompoint, BSc (Stats); Sandrine Stepien, MBiostat; Robyn W hittaker, MPH; Anthony Rodgers, MBChB, PhD; Aravinda Thiagalingam, MBChB, PhD Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial R3. 박민아 / pf. 우종신 JAMA. 2015;314(12):

Introduction Globally, cardiovascular disease is the leading cause of death and dis ease burden Many treatments and treatment strategies are proven to reduce the risk of major cardiovascular events Interventions that modify lifestyle factors are among the most effective but are poorly adhered to Secondary prevention is an effective way to reduce the burden of cardiovascular disease and is a current priority of the World Heart Federation : utilization of preventive drugs, control of risk factors, and uptake of lifestyle-changing behaviors

Introduction Cardiac rehabilitation programs : meta-regression analysis of 63 randomized trials of patients : associated with lower mortality and recurrent myocardial infarction : barriers to use - distance to services and time pressures  need to develop simple, low cost, widely available alternatives to improve the adoption of healthy lifestyles Mobile phone text messages to remind, encourage, and motivate patients might be useful

Introduction Purpose  Evaluate, in a randomized clinical trial, the effect of a text message–based intervention to encourage lifestyle change on objective measures of cardiovascular risk in individuals with coronary heart disease (CHD)

Methods  Study Design  TheTobacco,Exercise and DietMessages (TEXTME)study : parallel-design, single-blind, randomized clinical trial enrolling 710 patients with CHD : objective measures of cardiovascular risk factors were obtained at baseline and 6months post randomization (LDL-C level, blood pressure, BMI, self-reported measures of physical activity, diet, and medications) : demographic information - using an open-ended question

Materials and Methods  Participants - Recruited at a large tertiary referral center and university teaching hospital in Sydney, Australia - Inclusion criteria older than 18 years had documented CHD - Exclusion criteria not have an active mobile phone or sufficient English language proficiency to read text messages congenital heart disease or coronary anomalies

Materials and Methods  Randomization - random allocation sequence ; uniform 1:1 allocation ratio Intervention participants : received, in addition to usual care, the 6- month prevention program of approximately 96 messages Control participants : received usual care  Intervention - text message–based prevention program - : involved delivery of regular semipersonalized text messages - : 4 messages per week for 24 weeks - : contents  4 modules (smoking, diet, physical activity, general - cardiovascular health) - : interactive communication did not occur

Materials and Methods  Trial Procedures - All participants were assessed at baseline and followed up at 6 months with a clinic visit (Fasting lipids levels, blood pressure, heart rate, BMI, waist circumference) primary outcome : level of plasma LDL-C at 6 months secondary outcome : sBP, BMI, total cholesterol level, waist circumference, heart rate, total physical activity, smoking status, the proportion achieving guideline levels of modifiable risk factors

Results September November 2013

Results

Conclusion Among patients with CHD, the use of a lifestyle-focused text messaging service compared with usual care resulted in amodest improvement in LDL-C level and moderate improvements in blood pressure, BMI, and smoking status